Beremagene Geperpavec: First Approval
This article summarizes the milestones in the development of beremagene geperpavec leading to this first approval for dystrophic epidermolysis bullosa.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Biotechnology | Cold Sores | Drugs & Pharmacology | Epidermolysis Bullosa | Gene Therapy | Genetics | Herpes | Marketing